The company's strategic moves appear to be setting the stage for sustained progress in the treatment of Demodex blepharitis. While analysts project continued sales growth, detailed financial ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

The company's strategic moves appear to be setting the stage for sustained progress in the treatment of Demodex blepharitis. While analysts project continued sales growth, detailed financial ...

Jonathan Faison runs the ROTY Biotech Community. Why he's high on Tarsus Pharmaceuticals and his #1 holding, SpringWorks ...

Watch on LiveTube Now 👉 Video: Betsy Sodaro Lands Her Most Unique Role Yet: an Eye Mite! #Ad ET teamed up with ‘Ghosts’ star ...